首页基础医学药理学药理学 03 药理学 药物代谢动力学.ppt

03 药理学 药物代谢动力学.ppt

页数:22页文件大小:379.5 KB来源: 药理学ppt课件

本课件为药理学课程中的《第二章药物代谢动力学》,围绕第二章药物代谢动力学、Routes of Drug、清除率(ml、时间 CAB 血药浓度等部分展开,逐页梳理概念、机制与临床应用要点,适合预习、课堂对照与考前复习。

第二章药物代谢动力学封面页,标示本课件的主题与Routes of Drug、清除率(ml、时间 CAB 血药浓度等内容。
Transformation Free,Systemic Circulation Bounddrug Freedrug Metabolites Locus of Action“receptors”Bound Free Tissue。
Acrossmembraneand,lipid Acrossaqueouschannel Carrier-mediatedtransport Outside Inside Manners of Transport Across。
查看本课件的文字版(共 22 页,供检索与复制)

第1页:第二章药物代谢动力学

第二章药物代谢动力学 Pharmacokinetics

第2页:Transformation Free

Transformation Free Systemic Circulation Bounddrug Freedrug Metabolites Locus of Action“receptors”Bound Free Tissue Reservoirs Bound Exceretion Absorption

第3页:Acrossmembraneand

Acrossmembraneand lipid Acrossaqueouschannel Carrier-mediatedtransport Outside Inside Manners of Transport Across Membrance Passive transport

第4页:Routes of Drug

Routes of Drug Administration Enteralwithin or by way of the GI tract Oral (PO), rectal, sublingual Parenteral Not within the alimentary canal Inhalation, IM, SC, IP, topical Central Into the brain or spinal cord Intrathecal

第5页:Routes of Drug

Routes of Drug Administrationcommon abbreviations…PO =per os= oral IV = intravenous = into the vein IM = intramuscular = into the muscle SC = subcutaneous = between the skin and muscle IP = intraperitoneal = within the peritoneal cavityicv = intracerebroventricular =directly into the ventricle of the brain

第6页:Factors Affecting

Factors Affecting Response to Drugs Dosage Route of Administration Rate of Absorption Rate of Elimination Physiochemical properties of the drugage, sex, species, metabolism, etc…

第7页:清除率(ml/min)504030201

清除率(ml/min)5040302010002468020400120153001234567 苯巴比妥[弱酸性药](狗)苯丙胺[弱碱性药](人)精神反应血浆药物浓度尿排泄量酸性尿(p H~5)碱性尿(p H~7)碱性尿 p H7.8-8.0 酸性尿 p H<7 排尿(ml/min)mmol/hm M 计分值尿 p H 值对药物排泄的影响

第8页:02040608010012002468

0204060801001200246810 血浆阿司匹林浓度(mg/L)时间(min)口服和静脉注射阿司匹林 659mg 后的时-量曲线

第9页:时间 CAB 血药浓度 MEC

时间 CAB 血药浓度 MEC 三种不同的生物利用度 A.吸收速度快、吸收量完全 B.吸收速度与 A 相同,但吸收量仅为 A 的 50%C.吸收量完全,但吸收速度为 A 的 50%

第10页:血浆地高辛浓度

血浆地高辛浓度(nmol/L)12345012 四种由不同药厂生产的相同剂量地高辛片剂的生物利用度时间(h)

第11页:Eliminationkinetics1

Eliminationkinetics1. First-ordereliminationkinetics

第12页:0210123456 稳态浓度药物浓度

0210123456 稳态浓度药物浓度 Css.max Css.min7 多次给药的时-量曲线

第13页:血药浓度 100200300802460

血药浓度 100200300802460002468100200300 时间(半衰期)10020030002460ABC8MTCMEC 三种不同给药方案对稳态浓度的影响 A.缩短给药时间 B.增加给药剂量 C.负荷量给药

第14页:2. Zero-orderelimina

2. Zero-ordereliminationkinetics

第15页:Pharmacokinetic

Pharmacokinetic Evaluation of Gepirone Immediate

Release Capsulesand Gepirone Extended

Release Tablets in Healthy Volunteers JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 92, NO. 9, SEPTEMBER 2003

第16页:Gepirone is a

Gepirone is a 5-HT1Aagonist forthe treatment of major depression.

half-life of3 h and good oralbioavailability, and undergoesextensive first-pass metabolism

第17页:Because of its rapid

Because of its rapid absorption andshort half-life, the gepirone-IR(immediate-release formulation) must beadministered at least twice daily.

This regimen results in high peakconcentrations and marked peak-to-trough fluctuations in plasmaconcentrations.

第18页:These fluctuations

These fluctuations may contribute to anincreased incidence of adverse events,such asnausea, dizziness, headache, andsomnolence, andhave the potential toresult in lower patient compliance andreduced effectiveness.

extended-release gepirone formulation(ER)immediate-release formulation(IR)

第19页:Figure 1. Mean

Figure 1. Mean gepirone plasma concentrationsfollowing administration of gepirone-IR formulations(10mgq12 h,n=12) or gepirone-ER formulations (ER-1:20 mg q24 h, n=12; ER-2: 20 mg q24 h, n=12; ER-3:25 mg q24 h, n=12).

第20页:

第21页:Figure 2. Mean 1-PP

Figure 2. Mean 1-PP plasma concentrations followingadministration of gepirone-IR formulations(10 mg q12 h, n=12) or gepirone-ER formulations (ER-1: 20 mg q24 h, n=12; ER-2: 20 mg q24 h, n=12; ER-3:25 mg q24 h, n=12).

第22页:

《药理学》课件目录

顶部目录